Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Peptides for infertility and assisted reproduction: what the evidence shows

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

At a glance

Several peptide drugs are standard, FDA approved tools in fertility care. GnRH antagonists (ganirelix, cetrorelix) prevent premature ovulation during IVF with live birth rates similar to long agonist protocols and less ovarian hyperstimulation syndrome, and hCG triggers ovulation. Pulsatile GnRH induces ovulation in hypothalamic amenorrhea. These are specialist prescribed drugs, not wellness peptides.

Evidence: Strongest: Human RCT evidence5 peptides gradedVerified: Verified Sep 30, 2026

Do peptides help with infertility and assisted reproduction?

5 peptides are graded for infertility and assisted reproduction on this page. The strongest grade is human RCT evidence, for cetrorelix, ganirelix, HCG (human chorionic gonadotropin), gonadorelin, and leuprolide. Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.

What is the standard of care for infertility and assisted reproduction?

Evaluate both partners (ovulation, tubal patency, uterine cavity, semen analysis); ovulation induction with letrozole or clomiphene; intrauterine insemination; IVF with gonadotropin stimulation, where a GnRH antagonist and an hCG or GnRH agonist trigger are standard.

Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.

Which peptides have been studied for infertility and assisted reproduction?

Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.

Peptides studied for Infertility and assisted reproduction with evidence grades
PeptideEvidence for this useNote
CetrorelixEvidence: Human RCT evidenceA Cochrane review of GnRH antagonist protocols found similar live birth rates and lower odds of ovarian hyperstimulation syndrome (odds ratio 0.61) versus agonist protocols; FDA approved as Cetrotide. [1] [5]
GanirelixEvidence: Human RCT evidenceOngoing pregnancy rates matched a long leuprolide protocol in 313 IVF patients, with a shorter treatment course; FDA approved. [1] [2] [7]
HCG (human chorionic gonadotropin)Evidence: Human RCT evidenceFDA labeled to induce ovulation in anovulatory women after menotropin pretreatment; widely used as the final egg maturation trigger in IVF. [6] [8]
GonadorelinEvidence: Human RCT evidenceIn a randomized trial in 30 women with hypothalamic amenorrhea and polycystic ovaries, clinical pregnancy occurred in 46% with pulsatile GnRH versus 0% with gonadotropins; a meta-analysis of 35 studies (3 randomized, 32 observational; 1,002 women) found high ovulation rates with little hyperstimulation; branded US products were discontinued. [3] [4] [9]
LeuprolideEvidence: Human RCT evidenceUsed off label in long agonist IVF protocols and served as the comparator in the ganirelix trial; not FDA labeled for fertility. [10]

Head-to-head comparisons

Cost and access

Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.

Frequently asked questions

Which peptide has the strongest evidence for infertility and assisted reproduction?

Cetrorelix, ganirelix, HCG (human chorionic gonadotropin), gonadorelin, and leuprolide have the strongest evidence among the peptides graded here, at human RCT evidence. Cetrorelix: A Cochrane review of GnRH antagonist protocols found similar live birth rates and lower odds of ovarian hyperstimulation syndrome (odds ratio 0.61) versus agonist protocols; FDA approved as Cetrotide. Ganirelix: Ongoing pregnancy rates matched a long leuprolide protocol in 313 IVF patients, with a shorter treatment course; FDA approved. HCG (human chorionic gonadotropin): FDA labeled to induce ovulation in anovulatory women after menotropin pretreatment; widely used as the final egg maturation trigger in IVF. Gonadorelin: In a randomized trial in 30 women with hypothalamic amenorrhea and polycystic ovaries, clinical pregnancy occurred in 46% with pulsatile GnRH versus 0% with gonadotropins; a meta-analysis of 35 studies (3 randomized, 32 observational; 1,002 women) found high ovulation rates with little hyperstimulation; branded US products were discontinued. Leuprolide: Used off label in long agonist IVF protocols and served as the comparator in the ganirelix trial; not FDA labeled for fertility. [1] [2] [3] [4] [5] [7]

Is any peptide FDA approved for infertility and assisted reproduction?

Cetrorelix, ganirelix, HCG (human chorionic gonadotropin), gonadorelin, and leuprolide are FDA approved drugs, but an approval covers only the indications on that label, so check the label before assuming it applies to infertility and assisted reproduction. [1] [2] [5] [7] [9]

Has any peptide been tested in a randomized trial for infertility and assisted reproduction?

Yes, for cetrorelix, ganirelix, HCG (human chorionic gonadotropin), gonadorelin, and leuprolide. Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [1] [2] [3] [4] [5] [7]

From the blog

  • Peptides for men, ranked by human evidence

    hCG, GLP-1 drugs, teriparatide, and tesamorelin have human trials and a lawful route. PT-141 is off-label in men; kisspeptin and melanotan II have no approval or 503A listing. Ranking, legality, WADA.

  • Peptides for women, ranked by human evidence

    GLP-1 drugs, teriparatide, abaloparatide, and Vyleesi (PT-141) have real trials in women. Kisspeptin is research-only and GHK-Cu rests on small skin studies. The ranking and legal status.

Sources

  1. [1]Gonadotrophin-releasing hormone antagonists for assisted reproductive technologyPubMed 27126581, 2016
  2. [2]Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulationPubMed 11163814, 2001
  3. [3]Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysisPubMed 29605411, 2018
  4. [4]Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndromePubMed 23298894, 2013
  5. [5]FDA prescribing information for Cetrotide (cetrorelix acetate for injection), via DailyMedFDA, 2023
  6. [6]FDA prescribing information for Novarel (chorionic gonadotropin for injection), via DailyMedFDA, 2025
  7. [7]FDA prescribing information for Ganirelix Acetate Injection, via DailyMedFDA, 2023
  8. [8]FDA prescribing information for Pregnyl (chorionic gonadotropin for injection), via DailyMedFDA, 2025
  9. [9]Drugs@FDA database (search gonadorelin for the discontinued Factrel and Lutrepulse approvals)FDA, 2026
  10. [10]FDA prescribing information for Lupron Depot (leuprolide acetate) injection, via DailyMedFDA, 2024